1. Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001; 96:773–775. PMID:
11280549.
Article
2. Domenech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008; 14:1373–1379. PMID:
18452205.
3. Maher MM, Nassar MI. Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease. Dig Dis Sci. 2009; 54:2456–2462. PMID:
19093204.
4. Papadakis KA, Tung JK, Binder SW, et al. Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. Am J Gastroenterol. 2001; 96:2137–2142. PMID:
11467645.
5. Rahier JF, Ben-Horin S, Chowers Y, et al. European evidencebased Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2009; 3:47–91. PMID:
21172250.
Article
6. Lawlor G, Moss AC. Cytomegalovirus in inflammatory bowel disease: pathogen or innocent bystander? Inflamm Bowel Dis. 2010; 16:1620–1627. PMID:
20232408.
Article
7. Drew WL. Diagnosis of cytomegalovirus infection. Rev Infect Dis. 1988; 10(Suppl 3):S468–S476. PMID:
2847283.
Article
8. Goodgame RW. Gastrointestinal cytomegalovirus disease. Ann Intern Med. 1993; 119:924–935. PMID:
8215005.
Article
9. Kambham N, Vij R, Cartwright CA, Longacre T. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004; 28:365–373. PMID:
15104299.
10. Almeida N, Romaozinho JM, Amaro P, Ferreira M, Cipriano MA, Leitao MC. Fatal mid-gastrointestinal bleeding by cytomegalovirus enteritis in an immunocompetent patient. Acta Gastroenterol Belg. 2009; 72:245–248. PMID:
19637782.
11. Frank D, Raicht RF. Intestinal perforation associated with cytomegalovirus infection in patients with acquired immune deficiency syndrome. Am J Gastroenterol. 1984; 79:201–205. PMID:
6322576.
12. Nagata N, Kobayakawa M, Shimbo T, et al. Diagnostic value of antigenemia assay for cytomegalovirus gastrointestinal disease in immunocompromised patients. World J Gastroenterol. 2011; 17:1185–1191. PMID:
21448424.
Article
13. Chun J, Lee C, Kwon JE, et al. Usefulness of the cytomegalovirus antigenemia assay in patients with ulcerative colitis. Intest Res. 2015; 13:50–59. PMID:
25691843.
Article
14. Kim JW, Boo SJ, Ye BD, et al. Clinical utility of cytomegalovirus antigenemia assay and blood cytomegalovirus DNA PCR for cytomegaloviral colitis patients with moderate to severe ulcerative colitis. J Crohns Colitis. 2014; 8:693–701. PMID:
24405983.
Article
15. Matsuoka K, Iwao Y, Mori T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007; 102:331–337. PMID:
17156136.
Article
16. Leveque N, Brixi-Benmansour H, Reig T, et al. Low frequency of cytomegalovirus infection during exacerbations of inflammatory bowel diseases. J Med Virol. 2010; 82:1694–1700. PMID:
20827767.
Article
17. Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011; 106:2001–2008. PMID:
21788989.
Article